{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:30:55Z","timestamp":1789731055192,"version":"4.0.1"},"reference-count":118,"publisher":"Japan Atherosclerosis Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,5,1]]},"DOI":"10.5551\/jat.rv22033","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T22:12:35Z","timestamp":1737151955000},"page":"535-549","source":"Crossref","is-referenced-by-count":16,"title":["Inflammasome Activation and Neutrophil Extracellular Traps in Atherosclerosis"],"prefix":"10.5551","volume":"32","author":[{"given":"Tadayoshi","family":"Karasawa","sequence":"first","affiliation":[{"name":"Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Fernandez DM, Rahman AH, Fernandez NF, Chudnovskiy A, Amir ED, Amadori L, Khan NS, Wong CK, Shamailova R, Hill CA, Wang Z, Remark R, Li JR, Pina C, Faries C, Awad AJ, Moss N, Bjorkegren JLM, Kim-Schulze S, Gnjatic S, Ma\u2019ayan A, Mocco J, Faries P, Merad M, Giannarelli C. Single-cell immune landscape of human atherosclerotic plaques. Nat Med, 2019; 25: 1576-1588","DOI":"10.1038\/s41591-019-0590-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Zernecke A, Winkels H, Cochain C, Williams JW, Wolf D, Soehnlein O, Robbins CS, Monaco C, Park I, McNamara CA, Binder CJ, Cybulsky MI, Scipione CA, Hedrick CC, Galkina EV, Kyaw T, Ghosheh Y, Dinh HQ, Ley K. Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas. Circ Res, 2020; 127: 402-426","DOI":"10.1161\/CIRCRESAHA.120.316903"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Tabas I, Bornfeldt KE. Macrophage Phenotype and Function in Different Stages of Atherosclerosis. Circ Res, 2016; 118: 653-667","DOI":"10.1161\/CIRCRESAHA.115.306256"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nidorf SM, Fiolet A, Abela GS. Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability. J Clin Lipidol, 2020; 14: 619-630","DOI":"10.1016\/j.jacl.2020.07.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nu\u00f1ez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature, 2010; 464: 1357-1361","DOI":"10.1038\/nature08938"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science, 2015; 349: 316-320","DOI":"10.1126\/science.aaa8064"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Karasawa T, Komada T, Baatarjav C, Aizawa E, Mizushina Y, Fujimura K, Gunji Y, Komori S, Aizawa H, Jing Tao CB, Matsumura T, Takahashi M. Caspase-11 deficiency attenuates neutrophil recruitment into the atherosclerotic lesion in apolipoprotein E-deficient mice. Biochem Biophys Res Commun, 2023; 686: 149158","DOI":"10.1016\/j.bbrc.2023.149158"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Westerterp M, Fotakis P, Ouimet M, Bochem AE, Zhang H, Molusky MM, Wang W, Abramowicz S, la Bastide-van Gemert S, Wang N, Welch CL, Reilly MP, Stroes ES, Moore KJ, Tall AR. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis. Circulation, 2018; 138: 898-912","DOI":"10.1161\/CIRCULATIONAHA.117.032636"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Schroder K, Tschopp J. The inflammasomes. Cell, 2010; 140: 821-832","DOI":"10.1016\/j.cell.2010.01.040"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Karasawa T, Takahashi M. Role of NLRP3 Inflammasomes in Atherosclerosis. J Atheroscler Thromb, 2017; 24: 443-451","DOI":"10.5551\/jat.RV17001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Broz P, Pelegr\u00edn P, Shao F. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol, 2020; 20: 143-157","DOI":"10.1038\/s41577-019-0228-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Barnett KC, Li S, Liang K, Ting JP. A 360\u00b0 view of the inflammasome: Mechanisms of activation, cell death, and diseases. Cell, 2023; 186: 2288-2312","DOI":"10.1016\/j.cell.2023.04.025"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Grebe A, Hoss F, Latz E. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circ Res, 2018; 122: 1722-1740","DOI":"10.1161\/CIRCRESAHA.118.311362"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fidler TP, Xue C, Yalcinkaya M, Hardaway B, Abramowicz S, Xiao T, Liu W, Thomas DG, Hajebrahimi MA, Pircher J, Silvestre-Roig C, Kotini AG, Luchsinger LL, Wei Y, Westerterp M, Snoeck HW, Papapetrou EP, Schulz C, Massberg S, Soehnlein O, Ebert B, Levine RL, Reilly MP, Libby P, Wang N, Tall AR. The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis. Nature, 2021; 592: 296-301","DOI":"10.1038\/s41586-021-03341-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Paulin N, Viola JR, Maas SL, de Jong R, Fernandes-Alnemri T, Weber C, Drechsler M, D\u00f6ring Y, Soehnlein O. Double-Strand DNA Sensing Aim2 Inflammasome Regulates Atherosclerotic Plaque Vulnerability. Circulation, 2018; 138: 321-323","DOI":"10.1161\/CIRCULATIONAHA.117.033098"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) He Y, Zeng MY, Yang D, Motro B, N\u00fa\u00f1ez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature, 2016; 530: 354-357","DOI":"10.1038\/nature16959"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Masumoto J, Taniguchi S, Ayukawa K, Sarvotham H, Kishino T, Niikawa N, Hidaka E, Katsuyama T, Higuchi T, Sagara J. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J Biol Chem, 1999; 274: 33835-8","DOI":"10.1074\/jbc.274.48.33835"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Andreeva L, David L, Rawson S, Shen C, Pasricha T, Pelegrin P, Wu H. NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation. Cell, 2021; 184: 6299-6312.e22","DOI":"10.1016\/j.cell.2021.11.011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Xiao L, Magupalli VG, Wu H. Cryo-EM structures of the active NLRP3 inflammasome disc. Nature, 2023; 613: 595-600","DOI":"10.1038\/s41586-022-05570-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Brennan MA, Cookson BT. Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol Microbiol, 2000; 38: 31-40","DOI":"10.1046\/j.1365-2958.2000.02103.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kayagaki N, Stowe IB, Lee BL, O\u2019Rourke K, Anderson K, Warming S, Cuellar T, Haley B, Roose-Girma M, Phung QT, Liu PS, Lill JR, Li H, Wu J, Kummerfeld S, Zhang J, Lee WP, Snipas SJ, Salvesen GS, Morris LX, Fitzgerald L, Zhang Y, Bertram EM, Goodnow CC, Dixit VM. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature, 2015; 526: 666-671","DOI":"10.1038\/nature15541"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature, 2015; 526: 660-665","DOI":"10.1038\/nature15514"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, Lieberman J. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature, 2016; 535: 153-158","DOI":"10.1038\/nature18629"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Burgener SS, Leborgne NGF, Snipas SJ, Salvesen GS, Bird PI, Benarafa C. Cathepsin G Inhibition by Serpinb1 and Serpinb6 Prevents Programmed Necrosis in Neutrophils and Monocytes and Reduces GSDMD-Driven Inflammation. Cell Rep, 2019; 27: 3646-3656.e5","DOI":"10.1016\/j.celrep.2019.05.065"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Karmakar M, Minns M, Greenberg EN, Diaz-Aponte J, Pestonjamasp K, Johnson JL, Rathkey JK, Abbott DW, Wang K, Shao F, Catz SD, Dubyak GR, Pearlman E. N-GSDMD trafficking to neutrophil organelles facilitates IL-1\u03b2 release independently of plasma membrane pores and pyroptosis. Nat Commun, 2020; 11: 2212","DOI":"10.1038\/s41467-020-16043-9"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Orning P, Weng D, Starheim K, Ratner D, Best Z, Lee B, Brooks A, Xia S, Wu H, Kelliher MA, Berger SB, Gough PJ, Bertin J, Proulx MM, Goguen JD, Kayagaki N, Fitzgerald KA, Lien E. Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death. Science, 2018; 362: 1064-1069","DOI":"10.1126\/science.aau2818"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Sarhan J, Liu BC, Muendlein HI, Li P, Nilson R, Tang AY, Rongvaux A, Bunnell SC, Shao F, Green DR, Poltorak A. Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection. Proc Natl Acad Sci U S A, 2018; 115: E10888-E10897","DOI":"10.1073\/pnas.1809548115"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Wang Y, Gao W, Shi X, Ding J, Liu W, He H, Wang K, Shao F. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature, 2017; 547: 99-103","DOI":"10.1038\/nature22393"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Xia S, Zhang Z, Magupalli VG, Pablo JL, Dong Y, Vora SM, Wang L, Fu TM, Jacobson MP, Greka A, Lieberman J, Ruan J, Wu H. Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature, 2021; 593: 607-611","DOI":"10.1038\/s41586-021-03478-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Rogers C, Erkes DA, Nardone A, Aplin AE, Fernandes-Alnemri T, Alnemri ES. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat Commun, 2019; 10: 1689","DOI":"10.1038\/s41467-019-09397-2"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Miao R, Jiang C, Chang WY, Zhang H, An J, Ho F, Chen P, Junqueira C, Amgalan D, Liang FG, Zhang J, Evavold CL, Hafner-Bratkovi\u010d I, Zhang Z, Fontana P, Xia S, Waldeck-Weiermair M, Pan Y, Michel T, Bar-Peled L, Wu H, Kagan JC, Kitsis RN, Zhang P, Liu X, Lieberman J. Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis. Immunity, 2023; 56: 2523-2541.e8","DOI":"10.1016\/j.immuni.2023.10.004"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Balasubramanian A, Hsu AY, Ghimire L, Tahir M, Devant P, Fontana P, Du G, Liu X, Fabin D, Kambara H, Xie X, Liu F, Hasegawa T, Xu R, Yu H, Chen M, Kolakowski S, Trauger S, Larsen MR, Wei W, Wu H, Kagan JC, Lieberman J, Luo HR. The palmitoylation of gasdermin D directs its membrane translocation and pore formation during pyroptosis. Sci Immunol, 2024; 9: eadn1452","DOI":"10.1126\/sciimmunol.adn1452"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Du G, Healy LB, David L, Walker C, El-Baba TJ, Lutomski CA, Goh B, Gu B, Pi X, Devant P, Fontana P, Dong Y, Ma X, Miao R, Balasubramanian A, Puthenveetil R, Banerjee A, Luo HR, Kagan JC, Oh SF, Robinson CV, Lieberman J, Wu H. ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D. Nature, 2024; 630: 437-446","DOI":"10.1038\/s41586-024-07373-5"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) R\u00fchl S, Shkarina K, Demarco B, Heilig R, Santos JC, Broz P. ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science, 2018; 362: 956-960","DOI":"10.1126\/science.aar7607"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Wu C, Lu W, Zhang Y, Zhang G, Shi X, Hisada Y, Grover SP, Zhang X, Li L, Xiang B, Shi J, Li XA, Daugherty A, Smyth SS, Kirchhofer D, Shiroishi T, Shao F, Mackman N, Wei Y, Li Z. Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis. Immunity, 2019; 50: 1401-1411.e4","DOI":"10.1016\/j.immuni.2019.04.003"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Yang X, Cheng X, Tang Y, Qiu X, Wang Y, Kang H, Wu J, Wang Z, Liu Y, Chen F, Xiao X, Mackman N, Billiar TR, Han J, Lu B. Bacterial Endotoxin Activates the Coagulation Cascade through Gasdermin D-Dependent Phosphatidylserine Exposure. Immunity, 2019; 51: 983-996.e6","DOI":"10.1016\/j.immuni.2019.11.005"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Evavold CL, Ruan J, Tan Y, Xia S, Wu H, Kagan JC. The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages. Immunity, 2018; 48: 35-44.e6","DOI":"10.1016\/j.immuni.2017.11.013"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Gross O, Yazdi AS, Thomas CJ, Masin M, Heinz LX, Guarda G, Quadroni M, Drexler SK, Tschopp J. Inflammasome activators induce interleukin-1\u03b1 secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity, 2012; 36: 388-400","DOI":"10.1016\/j.immuni.2012.01.018"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Aizawa E, Karasawa T, Watanabe S, Komada T, Kimura H, Kamata R, Ito H, Hishida E, Yamada N, Kasahara T, Mori Y, Takahashi M. GSDME-Dependent Incomplete Pyroptosis Permits Selective IL-1\u03b1 Release under Caspase-1 Inhibition. iScience, 2020; 23: 101070","DOI":"10.1016\/j.isci.2020.101070"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Tsuchiya K, Hosojima S, Hara H, Kushiyama H, Mahib MR, Kinoshita T, Suda T. Gasdermin D mediates the maturation and release of IL-1\u03b1 downstream of inflammasomes. Cell Rep, 2021; 34: 108887","DOI":"10.1016\/j.celrep.2021.108887"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Kayagaki N, Kornfeld OS, Lee BL, Stowe IB, O\u2019Rourke K, Li Q, Sandoval W, Yan D, Kang J, Xu M, Zhang J, Lee WP, McKenzie BS, Ulas G, Payandeh J, Roose-Girma M, Modrusan Z, Reja R, Sagolla M, Webster JD, Cho V, Andrews TD, Morris LX, Miosge LA, Goodnow CC, Bertram EM, Dixit VM. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature, 2021; 591: 131-136","DOI":"10.1038\/s41586-021-03218-7"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Degen M, Santos JC, Pluhackova K, Cebrero G, Ramos S, Jankevicius G, Hartenian E, Guillerm U, Mari SA, Kohl B, M\u00fcller DJ, Schanda P, Maier T, Perez C, Sieben C, Broz P, Hiller S. Structural basis of NINJ1-mediated plasma membrane rupture in cell death. Nature, 2023; 618: 1065-1071","DOI":"10.1038\/s41586-023-05991-z"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Liston A, Masters SL. Homeostasis-altering molecular processes as mechanisms of inflammasome activation. Nat Rev Immunol, 2017; 17: 208-214","DOI":"10.1038\/nri.2016.151"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Karasawa T, Kawashima A, Usui-Kawanishi F, Watanabe S, Kimura H, Kamata R, Shirasuna K, Koyama Y, Sato-Tomita A, Matsuzaka T, Tomoda H, Park SY, Shibayama N, Shimano H, Kasahara T, Takahashi M. Saturated Fatty Acids Undergo Intracellular Crystallization and Activate the NLRP3 Inflammasome in Macrophages. Arterioscler Thromb Vasc Biol, 2018; 38: 744-756","DOI":"10.1161\/ATVBAHA.117.310581"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Anzai F, Karasawa T, Komada T, Yamada N, Miura Y, Sampilvanjil A, Baatarjav C, Fujimura K, Matsumura T, Tago K, Kurosu H, Takeishi Y, Kuro OM, Takahashi M. Calciprotein Particles Induce IL-1\u03b2\/\u03b1-Mediated Inflammation through NLRP3 Inflammasome-Dependent and -Independent Mechanisms. Immunohorizons, 2021; 5: 602-614","DOI":"10.4049\/immunohorizons.2100066"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Mu\u00f1oz-Planillo R, Kuffa P, Mart\u00ednez-Col\u00f3n G, Smith BL, Rajendiran TM, N\u00fa\u00f1ez G. K<sup>\uff0b<\/sup> efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity, 2013; 38: 1142-1153","DOI":"10.1016\/j.immuni.2013.05.016"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB, Becker CE, Ediriweera HN, Mullick AE, Golenbock DT, Stuart LM, Latz E, Fitzgerald KA, Moore KJ. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol, 2013; 14: 812-820","DOI":"10.1038\/ni.2639"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Baumer Y, McCurdy S, Weatherby TM, Mehta NN, Halbherr S, Halbherr P, Yamazaki N, Boisvert WA. Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis. Nat Commun, 2017; 8: 1129","DOI":"10.1038\/s41467-017-01186-z"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Wakabayashi T, Takahashi M, Yamamuro D, Karasawa T, Takei A, Takei S, Yamazaki H, Nagashima S, Ebihara K, Ishibashi S. Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow. Arterioscler Thromb Vasc Biol, 2018; 38: 2576-2589","DOI":"10.1161\/ATVBAHA.118.311648"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Sacks FM, Lichtenstein AH, Wu JHY, Appel LJ, Creager MA, Kris-Etherton PM, Miller M, Rimm EB, Rudel LL, Robinson JG, Stone NJ, Van Horn LV, American Heart A. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation, 2017; 136: e1-e23","DOI":"10.1161\/CIR.0000000000000510"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity, 2014; 41: 36-48","DOI":"10.1016\/j.immuni.2014.05.010"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Lancaster GI, Langley KG, Berglund NA, Kammoun HL, Reibe S, Estevez E, Weir J, Mellett NA, Pernes G, Conway JRW, Lee MKS, Timpson P, Murphy AJ, Masters SL, Gerondakis S, Bartonicek N, Kaczorowski DC, Dinger ME, Meikle PJ, Bond PJ, Febbraio MA. Evidence that TLR4 Is Not a Receptor for Saturated Fatty Acids but Mediates Lipid-Induced Inflammation by Reprogramming Macrophage Metabolism. Cell Metab, 2018; 27: 1096-1110.e5","DOI":"10.1016\/j.cmet.2018.03.014"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, Ting JP. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol, 2011; 12: 408-415","DOI":"10.1038\/ni.2022"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Weber K, Schilling JD. Lysosomes integrate metabolic-inflammatory cross-talk in primary macrophage inflammasome activation. J Biol Chem, 2014; 289: 9158-9171","DOI":"10.1074\/jbc.M113.531202"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) L\u2019Homme L, Esser N, Riva L, Scheen A, Paquot N, Piette J, Legrand-Poels S. Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes\/macrophages. J Lipid Res, 2013; 54: 2998-3008","DOI":"10.1194\/jlr.M037861"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Moon JS, Nakahira K, Chung KP, DeNicola GM, Koo MJ, Pab\u00f3n MA, Rooney KT, Yoon JH, Ryter SW, Stout-Delgado H, Choi AMK. Retraction Note: NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages. Nat Med, 2023; 29: 3272","DOI":"10.1038\/s41591-023-02723-8"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Moon JS, Lee S, Park MA, Siempos, II, Haslip M, Lee PJ, Yun M, Kim CK, Howrylak J, Ryter SW, Nakahira K, Choi AM. UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis. J Clin Invest, 2023; 133: e169986","DOI":"10.1172\/JCI169986"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Kuro OM. Phosphate as a Pathogen of Arteriosclerosis and Aging. J Atheroscler Thromb, 2021; 28: 203-213","DOI":"10.5551\/jat.RV17045"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Miura Y, Iwazu Y, Shiizaki K, Akimoto T, Kotani K, Kurabayashi M, Kurosu H, Kuro OM. Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease. Sci Rep, 2018; 8: 1256","DOI":"10.1038\/s41598-018-19677-4"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Nakazato J, Hoshide S, Wake M, Miura Y, Kuro OM, Kario K. Association of calciprotein particles measured by a new method with coronary artery plaque in patients with coronary artery disease: A cross-sectional study. J Cardiol, 2019; 74: 428-435","DOI":"10.1016\/j.jjcc.2019.04.008"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Shiizaki K, Tsubouchi A, Miura Y, Seo K, Kuchimaru T, Hayashi H, Iwazu Y, Miura M, Battulga B, Ohno N, Hara T, Kunishige R, Masutani M, Negishi K, Kario K, Kotani K, Yamada T, Nagata D, Komuro I, Itoh H, Kurosu H, Murata M, Kuro OM. Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression. J Clin Invest, 2021; 131: e145693","DOI":"10.1172\/JCI145693"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) J\u00e4ger E, Murthy S, Schmidt C, Hahn M, Strobel S, Peters A, St\u00e4ubert C, Sungur P, Venus T, Geisler M, Radusheva V, Raps S, Rothe K, Scholz R, Jung S, Wagner S, Pierer M, Seifert O, Chang W, Estrela-Lopis I, Raulien N, Krohn K, Str\u00e4ter N, Hoeppener S, Sch\u00f6neberg T, Rossol M, Wagner U. Calcium-sensing receptor-mediated NLRP3 inflammasome response to calciprotein particles drives inflammation in rheumatoid arthritis. Nat Commun, 2020; 11: 4243","DOI":"10.1038\/s41467-020-17749-6"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Neels JG, Gollentz C, Chinetti G. Macrophage death in atherosclerosis: potential role in calcification. Front Immunol, 2023; 14: 1215612","DOI":"10.3389\/fimmu.2023.1215612"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Usui F, Shirasuna K, Kimura H, Tatsumi K, Kawashima A, Karasawa T, Hida S, Sagara J, Taniguchi S, Takahashi M. Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. Biochem Biophys Res Commun, 2012; 425: 162-168","DOI":"10.1016\/j.bbrc.2012.07.058"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Jin C, Frayssinet P, Pelker R, Cwirka D, Hu B, Vignery A, Eisenbarth SC, Flavell RA. NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy. Proc Natl Acad Sci U S A, 2011; 108: 14867-14872","DOI":"10.1073\/pnas.1111101108"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Mariathasan S, Weiss DS, Newton K, McBride J, O\u2019Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature, 2006; 440: 228-232","DOI":"10.1038\/nature04515"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Stachon P, Heidenreich A, Merz J, Hilgendorf I, Wolf D, Willecke F, von Garlen S, Albrecht P, H\u00e4rdtner C, Ehrat N, Hoppe N, Rein\u00f6hl J, von Zur M\u00fchlen C, Bode C, Idzko M, Zirlik A. P2X(7) Deficiency Blocks Lesional Inflammasome Activity and Ameliorates Atherosclerosis in Mice. Circulation, 2017; 135: 2524-2533","DOI":"10.1161\/CIRCULATIONAHA.117.027400"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Yang D, He Y, Mu\u00f1oz-Planillo R, Liu Q, N\u00fa\u00f1ez G. Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock. Immunity, 2015; 43: 923-932","DOI":"10.1016\/j.immuni.2015.10.009"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, Miyake K, Zhang J, Lee WP, Muszy\u0144ski A, Forsberg LS, Carlson RW, Dixit VM. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science, 2013; 341: 1246-1249","DOI":"10.1126\/science.1240248"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Zanoni I, Tan Y, Di Gioia M, Broggi A, Ruan J, Shi J, Donado CA, Shao F, Wu H, Springstead JR, Kagan JC. An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells. Science, 2016; 352: 1232-1236","DOI":"10.1126\/science.aaf3036"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Chu LH, Indramohan M, Ratsimandresy RA, Gangopadhyay A, Morris EP, Monack DM, Dorfleutner A, Stehlik C. The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages. Nat Commun, 2018; 9: 996","DOI":"10.1038\/s41467-018-03409-3"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Choi YJ, Kim S, Choi Y, Nielsen TB, Yan J, Lu A, Ruan J, Lee HR, Wu H, Spellberg B, Jung JU. SERPINB1-mediated checkpoint of inflammatory caspase activation. Nat Immunol, 2019; 20: 276-287","DOI":"10.1038\/s41590-018-0303-z"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Gage J, Hasu M, Thabet M, Whitman SC. Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice. Can J Cardiol, 2012; 28: 222-229","DOI":"10.1016\/j.cjca.2011.10.013"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Menu P, Pellegrin M, Aubert JF, Bouzourene K, Tardivel A, Mazzolai L, Tschopp J. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. Cell Death Dis, 2011; 2: e137","DOI":"10.1038\/cddis.2011.18"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol, 2003; 23: 656-660","DOI":"10.1161\/01.ATV.0000064374.15232.C3"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Vromman A, Ruvkun V, Shvartz E, Wojtkiewicz G, Santos Masson G, Tesmenitsky Y, Folco E, Gram H, Nahrendorf M, Swirski FK, Sukhova GK, Libby P. Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis. Eur Heart J, 2019; 40: 2482-2491","DOI":"10.1093\/eurheartj\/ehz008"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Gomez D, Baylis RA, Durgin BG, Newman AAC, Alencar GF, Mahan S, St Hilaire C, M\u00fcller W, Waisman A, Francis SE, Pinteaux E, Randolph GJ, Gram H, Owens GK. Interleukin-1\u03b2 has atheroprotective effects in advanced atherosclerotic lesions of mice. Nat Med, 2018; 24: 1418-1429","DOI":"10.1038\/s41591-018-0124-5"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78) Imai T, Oikawa Y, Shimada A, Oguchi S, Takamiya Y, Katsuki T, Okubo Y, Osaki T, Tahara H, Matsushima Y, Miyazaki J, Itoh H. Proatherogenic effect of interleukin-18 is exerted with high-fat diet, but not with normal diet in spontaneously hyperlipidemic mice. J Atheroscler Thromb, 2011; 18: 1090-1101","DOI":"10.5551\/jat.7567"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Bhat OM, Kumar PU, Giridharan NV, Kaul D, Kumar MJ, Dhawan V. Interleukin-18-induced atherosclerosis involves CD36 and NF-\u03baB crosstalk in Apo E-\/- mice. J Cardiol, 2015; 66: 28-35","DOI":"10.1016\/j.jjcc.2014.10.012"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) Elhage R, Jawien J, Rudling M, Ljunggren HG, Takeda K, Akira S, Bayard F, Hansson GK. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res, 2003; 59: 234-240","DOI":"10.1016\/S0008-6363(03)00343-2"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81) Pejnovic N, Vratimos A, Lee SH, Popadic D, Takeda K, Akira S, Chan WL. Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet. Mol Immunol, 2009; 47: 37-45","DOI":"10.1016\/j.molimm.2008.12.032"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82) Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ Res, 2012; 110: 875-888","DOI":"10.1161\/CIRCRESAHA.111.257535"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O. Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol, 2020; 17: 327-340","DOI":"10.1038\/s41569-019-0326-7"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84) Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation, 2010; 122: 1837-1845","DOI":"10.1161\/CIRCULATIONAHA.110.961714"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85) D\u00f6ring Y, Drechsler M, Wantha S, Kemmerich K, Lievens D, Vijayan S, Gallo RL, Weber C, Soehnlein O. Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ Res, 2012; 110: 1052-1056","DOI":"10.1161\/CIRCRESAHA.112.265868"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86) Wantha S, Alard JE, Megens RT, van der Does AM, D\u00f6ring Y, Drechsler M, Pham CT, Wang MW, Wang JM, Gallo RL, von Hundelshausen P, Lindbom L, Hackeng T, Weber C, Soehnlein O. Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. Circ Res, 2013; 112: 792-801","DOI":"10.1161\/CIRCRESAHA.112.300666"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87) Alard JE, Ortega-Gomez A, Wichapong K, Bongiovanni D, Horckmans M, Megens RT, Leoni G, Ferraro B, Rossaint J, Paulin N, Ng J, Ippel H, Suylen D, Hinkel R, Blanchet X, Gaillard F, D\u2019Amico M, von Hundelshausen P, Zarbock A, Scheiermann C, Hackeng TM, Steffens S, Kupatt C, Nicolaes GA, Weber C, Soehnlein O. Recruitment of classical monocytes can be inhibited by disturbing heteromers of neutrophil HNP1 and platelet CCL5. Sci Transl Med, 2015; 7: 317ra196","DOI":"10.1126\/scitranslmed.aad5330"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88) Ortega-Gomez A, Salvermoser M, Rossaint J, Pick R, Brauner J, Lemnitzer P, Tilgner J, de Jong RJ, Megens RT, Jamasbi J, D\u00f6ring Y, Pham CT, Scheiermann C, Siess W, Drechsler M, Weber C, Grommes J, Zarbock A, Walzog B, Soehnlein O. Cathepsin G Controls Arterial But Not Venular Myeloid Cell Recruitment. Circulation, 2016; 134: 1176-1188","DOI":"10.1161\/CIRCULATIONAHA.116.024790"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89) Ionita MG, van den Borne P, Catanzariti LM, Moll FL, de Vries JP, Pasterkamp G, Vink A, de Kleijn DP. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol, 2010; 30: 1842-1848","DOI":"10.1161\/ATVBAHA.110.209296"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90) Silvestre-Roig C, Braster Q, Wichapong K, Lee EY, Teulon JM, Berrebeh N, Winter J, Adrover JM, Santos GS, Froese A, Lemnitzer P, Ortega-G\u00f3mez A, Chevre R, Marschner J, Schumski A, Winter C, Perez-Olivares L, Pan C, Paulin N, Schoufour T, Hartwig H, Gonz\u00e1lez-Ramos S, Kamp F, Megens RTA, Mowen KA, Gunzer M, Maegdefessel L, Hackeng T, Lutgens E, Daemen M, von Blume J, Anders HJ, Nikolaev VO, Pellequer JL, Weber C, Hidalgo A, Nicolaes GAF, Wong GCL, Soehnlein O. Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death. Nature, 2019; 569: 236-240","DOI":"10.1038\/s41586-019-1167-6"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91) Lenglet S, Mach F, Montecucco F. Role of matrix metalloproteinase-8 in atherosclerosis. Mediators Inflamm, 2013; 2013: 659282","DOI":"10.1155\/2013\/659282"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92) D\u00f6ring Y, Soehnlein O, Weber C. Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis. Circ Res, 2017; 120: 736-743","DOI":"10.1161\/CIRCRESAHA.116.309692"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93) Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D\u2019Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, Garc\u00eda-S\u00e1ez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, J\u00e4\u00e4ttel\u00e4 M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, L\u00f3pez-Ot\u00edn C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Mu\u00f1oz-Pinedo C, Nagata S, Nu\u00f1ez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ, 2018; 25: 486-541","DOI":"10.1038\/s41418-017-0012-4"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94) D\u00f6ring Y, Manthey HD, Drechsler M, Lievens D, Megens RT, Soehnlein O, Busch M, Manca M, Koenen RR, Pelisek J, Daemen MJ, Lutgens E, Zenke M, Binder CJ, Weber C, Zernecke A. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation, 2012; 125: 1673-1683","DOI":"10.1161\/CIRCULATIONAHA.111.046755"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95) Knight JS, Luo W, O\u2019Dell AA, Yalavarthi S, Zhao W, Subramanian V, Guo C, Grenn RC, Thompson PR, Eitzman DT, Kaplan MJ. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis. Circ Res, 2014; 114: 947-956","DOI":"10.1161\/CIRCRESAHA.114.303312"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96) Mitroulis I, Kambas K, Chrysanthopoulou A, Skendros P, Apostolidou E, Kourtzelis I, Drosos GI, Boumpas DT, Ritis K. Neutrophil extracellular trap formation is associated with IL-1\u03b2 and autophagy-related signaling in gout. PLoS One, 2011; 6: e29318","DOI":"10.1371\/journal.pone.0029318"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97) Mu\u00f1oz LE, Bilyy R, Biermann MH, Kienh\u00f6fer D, Mauer\u00f6der C, Hahn J, Brauner JM, Weidner D, Chen J, Scharin-Mehlmann M, Janko C, Friedrich RP, Mielenz D, Dumych T, Lootsik MD, Schauer C, Schett G, Hoffmann M, Zhao Y, Herrmann M. Nanoparticles size-dependently initiate self-limiting NETosis-driven inflammation. Proc Natl Acad Sci U S A, 2016; 113: E5856-E5865","DOI":"10.1073\/pnas.1602230113"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98) Franck G, Mawson TL, Folco EJ, Molinaro R, Ruvkun V, Engelbertsen D, Liu X, Tesmenitsky Y, Shvartz E, Sukhova GK, Michel JB, Nicoletti A, Lichtman A, Wagner D, Croce KJ, Libby P. Roles of PAD4 and NETosis in Experimental Atherosclerosis and Arterial Injury: Implications for Superficial Erosion. Circ Res, 2018; 123: 33-42","DOI":"10.1161\/CIRCRESAHA.117.312494"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99) Chauhan D, Demon D, Vande Walle L, Paerewijck O, Zecchin A, Bosseler L, Santoni K, Plan\u00e8s R, Ribo S, Fossoul A, Gon\u00e7alves A, Van Gorp H, Van Opdenbosch N, Van Hauwermeiren F, Meunier E, Wullaert A, Lamkanfi M. GSDMD drives canonical inflammasome-induced neutrophil pyroptosis and is dispensable for NETosis. EMBO Rep, 2022; 23: e54277","DOI":"10.15252\/embr.202154277"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100) Chen KW, Monteleone M, Boucher D, Sollberger G, Ramnath D, Condon ND, von Pein JB, Broz P, Sweet MJ, Schroder K. Noncanonical inflammasome signaling elicits gasdermin D-dependent neutrophil extracellular traps. Sci Immunol, 2018; 3: eaar6676","DOI":"10.1126\/sciimmunol.aar6676"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101) Sollberger G, Choidas A, Burn GL, Habenberger P, Di Lucrezia R, Kordes S, Menninger S, Eickhoff J, Nussbaumer P, Klebl B, Kr\u00fcger R, Herzig A, Zychlinsky A. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Sci Immunol, 2018; 3: eaar6689","DOI":"10.1126\/sciimmunol.aar6689"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102) Coll RC, Schroder K, Pelegr\u00edn P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci, 2022; 43: 653-668","DOI":"10.1016\/j.tips.2022.04.003"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103) Toldo S, Mezzaroma E, Buckley LF, Potere N, Di Nisio M, Biondi-Zoccai G, Van Tassell BW, Abbate A. Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacol Ther, 2022; 236: 108053","DOI":"10.1016\/j.pharmthera.2021.108053"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104) Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med, 2017; 377: 1119-1131","DOI":"10.1056\/NEJMoa1707914"},{"key":"105","unstructured":"105) Deftereos SG, Beerkens FJ, Shah B, Giannopoulos G, Vrachatis DA, Giotaki SG, Siasos G, Nicolas J, Arnott C, Patel S, Parsons M, Tardif JC, Kovacic JC, Dangas GD. Colchicine in Cardiovascular Disease: In-Depth Review. Circulation, 2022; 145: 61-78"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106) Robinson KP, Chan JJ. Colchicine in dermatology: A review. Australas J Dermatol, 2018; 59: 278-285","DOI":"10.1111\/ajd.12795"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107) Chappey ON, Niel E, Wautier JL, Hung PP, Dervichian M, Cattan D, Scherrmann JM. Colchicine disposition in human leukocytes after single and multiple oral administration. Clin Pharmacol Ther, 1993; 54: 360-367","DOI":"10.1038\/clpt.1993.161"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108) Vaidya K, Tucker B, Kurup R, Khandkar C, Pandzic E, Barraclough J, Machet J, Misra A, Kavurma M, Martinez G, Rye KA, Cochran BJ, Patel S. Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention. J Am Heart Assoc, 2021; 10: e018993","DOI":"10.1161\/JAHA.120.018993"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109) Li YW, Chen SX, Yang Y, Zhang ZH, Zhou WB, Huang YN, Huang ZQ, He JQ, Chen TF, Wang JF, Liu ZY, Chen YX. Colchicine Inhibits NETs and Alleviates Cardiac Remodeling after Acute Myocardial Infarction. Cardiovasc Drugs Ther, 2024; 38: 31-41","DOI":"10.1007\/s10557-022-07326-y"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110) Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature, 2006; 440: 237-241","DOI":"10.1038\/nature04516"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111) Misawa T, Takahama M, Kozaki T, Lee H, Zou J, Saitoh T, Akira S. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol, 2013; 14: 454-460","DOI":"10.1038\/ni.2550"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112) Park YH, Wood G, Kastner DL, Chae JJ. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol, 2016; 17: 914-921","DOI":"10.1038\/ni.3457"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113) Gao W, Yang J, Liu W, Wang Y, Shao F. Site-specific phosphorylation and microtubule dynamics control Pyrin inflammasome activation. Proc Natl Acad Sci U S A, 2016; 113: E4857- E4866","DOI":"10.1073\/pnas.1601700113"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114) Van Gorp H, Saavedra PH, de Vasconcelos NM, Van Opdenbosch N, Vande Walle L, Matusiak M, Prencipe G, Insalaco A, Van Hauwermeiren F, Demon D, Bogaert DJ, Dullaers M, De Baere E, Hochepied T, Dehoorne J, Vermaelen KY, Haerynck F, De Benedetti F, Lamkanfi M. Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation. Proc Natl Acad Sci U S A, 2016; 113: 14384-14389","DOI":"10.1073\/pnas.1613156113"},{"key":"115","doi-asserted-by":"crossref","unstructured":"115) Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol, 2013; 61: 404-410","DOI":"10.1016\/j.jacc.2012.10.027"},{"key":"116","doi-asserted-by":"crossref","unstructured":"116) Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu XF, Ireland MA, Lenderink T, Latchem D, Hoogslag P, Jerzewski A, Nierop P, Whelan A, Hendriks R, Swart H, Schaap J, Kuijper AFM, van Hessen MWJ, Saklani P, Tan I, Thompson AG, Morton A, Judkins C, Bax WA, Dirksen M, Alings M, Hankey GJ, Budgeon CA, Tijssen JGP, Cornel JH, Thompson PL. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med, 2020; 383: 1838-1847","DOI":"10.1056\/NEJMoa2021372"},{"key":"117","doi-asserted-by":"crossref","unstructured":"117) Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, Berry C, L\u00f3pez-Send\u00f3n J, Ostadal P, Koenig W, Angoulvant D, Gr\u00e9goire JC, Lavoie MA, Dub\u00e9 MP, Rhainds D, Provencher M, Blondeau L, Orfanos A, L\u2019Allier PL, Guertin MC, Roubille F. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med, 2019; 381: 2497-2505","DOI":"10.1056\/NEJMoa1912388"},{"key":"118","doi-asserted-by":"crossref","unstructured":"118) Samuel M, Tardif JC, Khairy P, Roubille F, Waters DD, Gr\u00e9goire JC, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Ostadal P, Lopez-Sendon J, Gamra H, Kiwan GS, Dub\u00e9 MP, Provencher M, Orfanos A, Blondeau L, Kouz S, L\u2019Allier PL, Ibrahim R, Bouabdallaoui N, Mitchell D, Guertin MC, Lelorier J. Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J Qual Care Clin Outcomes, 2021; 7: 486-495","DOI":"10.1093\/ehjqcco\/qcaa045"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/5\/32_RV22033\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:12:08Z","timestamp":1746245528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/5\/32_RV22033\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":118,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.rv22033","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"article-number":"RV22033"}}